Login
$TLSI
$2.27 +$0.00 (0.0%) After hours

$TLSI SEC Filings

Filed On Filing
16 Nov 2026 SCHEDULE 13G/A
16 Nov 2026 Form 4: Wahlstrom Mats, Director

Bought 50,000 shares ($112K)

10 Nov 2026 10-Q
10 Nov 2026 8-K: Results of Operations and Financial Condition

Generated third quarter revenue of $12.9 million, driven by expanded commercial organization and increasing market penetration

07 Oct 2026 Form 4: Cox Bryan F., Chief of Research

Sold 296 shares ($1.3K)

07 Oct 2026 Form 4: Marshak Richard, Chief Commercial Officer

Sold 325 shares ($1.43K)

07 Oct 2026 Form 4: Stevens Jennifer, Chief Regulatory Officer

Sold 316 shares ($1.39K)

07 Oct 2026 Form 4: Szela Mary T, Director

Gave up 2,693 shares to cover exercise price or tax ($11.8K)

22 Sep 2026 8-K: Other Events

TriSalus Life Sciences Receives FDA Clearance for TriNav® Advance, Strengthening Comprehensive Pressure-Enabled Drug DeliveryTM (PEDDTM) Portfolio for Liver Embolization

06 Aug 2026 10-Q
06 Aug 2026 8-K: Results of Operations and Financial Condition

Generated second quarter revenue of $11.4 million and expanded commercial organization to support future growth and broader market penetration

07 Jul 2026 SCHEDULE 13G/A
06 Jul 2026 Form 4: Patience David, Chief Financial Officer

Gave up 14,650 shares to cover exercise price or tax ($65.3K)

01 Jul 2026 Form 4: Szela Mary T, Director

Received 3,990 shares as a grant or award ($15.4K)

01 Jul 2026 Form 5: Szela Mary T, Director

Received 3,530 shares as a grant or award ($15K) · Received 2,848 shares as a grant or award ($12K) · Received 2,100 shares as a grant or award ($9.2K)

01 Jul 2026 Form 4: Marshak Richard, Chief Commercial Officer

Received 561 shares as a grant or award ($2.17K)

01 Jul 2026 Form 5: Marshak Richard, Chief Commercial Officer

Received 279 shares as a grant or award ($1.31K) · Received 999 shares as a grant or award ($4.26K) · Received 930 shares as a grant or award ($3.93K) · 1 more

29 Jun 2026 Form 4: Marshall Richard Henry, Chief Medical Officer

Received 60,000 shares as a grant or award · Granted 120,000 Employee Stock Option (right to buy)

29 Jun 2026 Form 3: Marshall Richard Henry, Chief Medical Officer

Holds 30,000 shares of Common Stock

20 May 2026 SCHEDULE 13G/A

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support